C1QTNF9 and atherosclerosis: Previous studies have shown CTRP9 to have potent anti-diabetic, anti-oxidative, and anti-inflammatory properties, being involved in multiple pathophysiological processes associated with atherosclerosis (Yu et al., 2018).